Authors: Challa S.S.R. Kumar; Carola Leuschner; E.E. Doomes; Larry Henry; Martha Juban; Josef Hormes
Source: Journal of Nanoscience and Nanotechnology, Volume 4, Number 3, March 2004 , pp. 245-249(5)
Publisher: American Scientific Publishers
Abstract:
A 23-amino-acid synthetic lytic peptide (Hecate) was covalently linked to magnetite nanoparticles and the lytic peptide-bound nanoparticles were characterized by X-ray absorption near-edge structure spectroscopy, transmission electron microscopy, and electron diffraction. Investigation of magnetic properties with a superconducting quantum interference device (SQUID) magnetometer has shown a reduction in the saturation magnetization (Ms) of magnetite nanoparticles after binding with lytic peptide. An in vitro cell culture assay with breast cancer cell lines MDA-MB-435S revealed that the lytic peptide-bound magnetite nanoparticles were therapeutically active.Keywords: MAGNETITE NANOPARTICLE; LYTIC PEPTIDE; BREAST CANCER CELLS
Document Type: Research article
DOI: 10.1166/jnn.2004.085
Links for this article